| Jorge Luis Solorzano, OD | |
|
1414 Arlington St, Ste 1400, Ada, OK 74820-2643 | |
| (580) 332-1880 | |
| (580) 332-2214 |
| Full Name | Jorge Luis Solorzano |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 22 Years |
| Location | 1414 Arlington St, Ada, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952304586 | NPI | - | NPPES |
| 2324338 | Other | OK | UNITED HEALTHCARE |
| 7200451 | Other | OK | AETNA |
| 200061320A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 2432 (Oklahoma) | Primary |
| Provider Name | Eyecare Associates Of South Tulsa Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1750475760 PECOS PAC ID: 4385646124 Enrollment ID: O20070208000133 |
News Archive
Canadian study findings suggest that many people overestimate the size of one serving of food and may overeat as a result.
Plexxikon Inc. announces that enrollment has been initiated and the first patient has been treated in the first of two pivotal trials of PLX4032 (RG7204) in patients with metastatic melanoma. PLX4032 is a novel, oral and highly selective drug that targets the BRAFV600E cancer-causing mutation occurring in about 50 percent of melanomas and about eight percent of all solid tumors.
European hematologists raise the alarm on the insufficient research money for blood disorders. "Blood cancers kill over 95,000 in the EU every year; the EU must be made aware that more research funds are needed", states Professor Robin Foa, President of the European Hematology Association (EHA) at their annual congress in London.
Many people with incurable brain tumors use alternative therapies, such as taking vitamins and homeopathy, in addition to their conventional treatments, according to a study published in the December 14, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology.
› Verified 3 days ago
| Provider Name | Norman Eye Clinic Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1477118073 PECOS PAC ID: 0446584494 Enrollment ID: O20190625000675 |
News Archive
Canadian study findings suggest that many people overestimate the size of one serving of food and may overeat as a result.
Plexxikon Inc. announces that enrollment has been initiated and the first patient has been treated in the first of two pivotal trials of PLX4032 (RG7204) in patients with metastatic melanoma. PLX4032 is a novel, oral and highly selective drug that targets the BRAFV600E cancer-causing mutation occurring in about 50 percent of melanomas and about eight percent of all solid tumors.
European hematologists raise the alarm on the insufficient research money for blood disorders. "Blood cancers kill over 95,000 in the EU every year; the EU must be made aware that more research funds are needed", states Professor Robin Foa, President of the European Hematology Association (EHA) at their annual congress in London.
Many people with incurable brain tumors use alternative therapies, such as taking vitamins and homeopathy, in addition to their conventional treatments, according to a study published in the December 14, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology.
› Verified 3 days ago
| Provider Name | Eye Medical Group, Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1457008864 PECOS PAC ID: 8820483662 Enrollment ID: O20220315000826 |
News Archive
Canadian study findings suggest that many people overestimate the size of one serving of food and may overeat as a result.
Plexxikon Inc. announces that enrollment has been initiated and the first patient has been treated in the first of two pivotal trials of PLX4032 (RG7204) in patients with metastatic melanoma. PLX4032 is a novel, oral and highly selective drug that targets the BRAFV600E cancer-causing mutation occurring in about 50 percent of melanomas and about eight percent of all solid tumors.
European hematologists raise the alarm on the insufficient research money for blood disorders. "Blood cancers kill over 95,000 in the EU every year; the EU must be made aware that more research funds are needed", states Professor Robin Foa, President of the European Hematology Association (EHA) at their annual congress in London.
Many people with incurable brain tumors use alternative therapies, such as taking vitamins and homeopathy, in addition to their conventional treatments, according to a study published in the December 14, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jorge Luis Solorzano, OD 1414 Arlington St, Ste 1400, Ada, OK 74820-2643 Ph: (580) 332-1880 | Jorge Luis Solorzano, OD 1414 Arlington St, Ste 1400, Ada, OK 74820-2643 Ph: (580) 332-1880 |
News Archive
Canadian study findings suggest that many people overestimate the size of one serving of food and may overeat as a result.
Plexxikon Inc. announces that enrollment has been initiated and the first patient has been treated in the first of two pivotal trials of PLX4032 (RG7204) in patients with metastatic melanoma. PLX4032 is a novel, oral and highly selective drug that targets the BRAFV600E cancer-causing mutation occurring in about 50 percent of melanomas and about eight percent of all solid tumors.
European hematologists raise the alarm on the insufficient research money for blood disorders. "Blood cancers kill over 95,000 in the EU every year; the EU must be made aware that more research funds are needed", states Professor Robin Foa, President of the European Hematology Association (EHA) at their annual congress in London.
Many people with incurable brain tumors use alternative therapies, such as taking vitamins and homeopathy, in addition to their conventional treatments, according to a study published in the December 14, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology.
› Verified 3 days ago
Elliott Vision Care, Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 1139 N Hills Ctr, Ada, OK 74820 Phone: 580-332-6000 Fax: 580-332-6006 | |
Courtney K Bratton, OD Optometrist Medicare: Medicare Enrolled Practice Location: 500 N Monte Vista St, Suite 3, Ada, OK 74820 Phone: 580-272-9600 Fax: 580-272-9602 | |
Advanced Eye Care Associates Optometrist Medicare: Medicare Enrolled Practice Location: 1433 Arlington St, Ada, OK 74820 Phone: 580-332-5606 Fax: 580-332-3946 | |
Travis W Thompson, Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1921 Stonecipher Dr, Ada, OK 74820 Phone: 580-436-3980 | |
Dr. Julie Kaylynn Wolfe, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1921 Stonecipher Dr, Ada, OK 74820 Phone: 580-421-4570 Fax: 580-421-6293 | |
Derek Gurley, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1433 Arlington St, Ada, OK 74820 Phone: 580-436-5606 | |
Mrs. Stacy G Presley, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1433 Arlington St, Ada, OK 74820 Phone: 580-332-5606 Fax: 580-332-3946 |